comparemela.com

Latest Breaking News On - Fennec pharmaceuticals inc - Page 11 : comparemela.com

Contrasting Fennec Pharmaceuticals (NASDAQ:FENC) and Century Therapeutics (NASDAQ:IPSC)

Fennec Pharmaceuticals (NASDAQ:FENC – Get Free Report) and Century Therapeutics (NASDAQ:IPSC – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends and profitability. Profitability This table compares Fennec Pharmaceuticals and […]

United-states
Philadelphia
Pennsylvania
Research-triangle-park
North-carolina
Century-therapeutics-inc
Fennec-pharmaceuticals-inc
Fennec-pharmaceuticals
News-ratings-for-fennec-pharmaceuticals-daily
Adherex-technologies-inc
Get-free-report

FY2027 EPS Estimates for Fennec Pharmaceuticals Inc Decreased by Analyst (NASDAQ:FENC)

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) – Investment analysts at Capital One Financial reduced their FY2027 earnings per share estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Thursday, August 3rd. Capital One Financial analyst N. Quibria now anticipates that the company will post earnings of $2.35 per share for […]

United-states
Gendell-jeffrey
Robert-andrade
Chrisa-rallis
Institutional-trading-of-fennec-pharmaceuticals
Opaleye-management-inc
Capital-management
News-ratings-for-fennec-pharmaceuticals-daily
Insider-transactions-at-fennec-pharmaceuticals
Fennec-pharmaceuticals-company-profile
Fennec-pharmaceuticals-stock-performance
Dg-capital-management

HC Wainwright Cuts Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $17.00

Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) had its target price lowered by HC Wainwright from $18.00 to $17.00 in a research note released on Friday morning, MarketBeat.com reports. The firm currently has a buy rating on the stock. Separately, Cantor Fitzgerald raised their price target on Fennec Pharmaceuticals from $12.00 to $16.00 and gave the […]

United-states
Robert-andrade
Gendell-jeffrey
Chrisa-rallis
Nasdaq
Hartford-financial-management-inc
Fennec-pharmaceuticals-inc
Fennec-pharmaceuticals
Trellus-management-company
Opaleye-management-inc
Cantor-fitzgerald
Fennec-pharmaceuticals-trading

HC Wainwright Lowers Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $17.00

Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) had its price objective trimmed by HC Wainwright from $18.00 to $17.00 in a research report report published on Friday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the stock. Separately, Cantor Fitzgerald raised their price target on Fennec Pharmaceuticals from $12.00 to $16.00 and gave […]

United-states
Chrisa-rallis
Robert-andrade
Opaleye-management-inc
Analyst-recommendations-for-fennec-pharmaceuticals
Fennec-pharmaceuticals-stock
Harbert-fund-advisors-inc
Securities-exchange-commission
Fennec-pharmaceuticals
Cantor-fitzgerald
News-ratings-for-fennec-pharmaceuticals-daily
Dg-capital-management

Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update

Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Oregon
Landierw-ototoxicity
Gentium-gmb
Adrian-haigh
Rosty-raykov
Robert-andrade
Lindsay-rocco
Children-oncology-group
Nasdaq
Fennec-pharmaceuticals-inc
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.